Surescripts Standardizes on Splunk Software to Target Healthcare Fraud
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Cantor Fitzgerald Remains Bullish Ahead of Splunk's (SPLK) 1Q Report
May 21, 2015 8:47 AM EDTCantor Fitzgerald maintains a Buy rating and $90 price target on Splunk (NASDAQ: SPLK) leading up to its 1Q16 results. Analyst Brian White believes that Splunk will at least meet his 1Q revenue estimate of $120.9m, and EPS estimate of ($0.04). Splunk is scheduled to report 1Q earnings on May... More
